Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.75p
   
  • Change Today:
    -0.25p
  • 52 Week High: 33.25
  • 52 Week Low: 8.90
  • Currency: UK Pounds
  • Shares Issued: 102.32m
  • Volume: 759,804
  • Market Cap: £11.00m
  • RiskGrade: 435

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
65.7% below the market average65.7% below the market average65.7% below the market average65.7% below the market average65.7% below the market average
34.48% below the sector average34.48% below the sector average34.48% below the sector average34.48% below the sector average34.48% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
47.01% below the market average47.01% below the market average47.01% below the market average47.01% below the market average47.01% below the market average
4.76% below the sector average4.76% below the sector average4.76% below the sector average4.76% below the sector average4.76% below the sector average
Price Chg 3m
76.63% below the market average76.63% below the market average76.63% below the market average76.63% below the market average76.63% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
36.06% above the market average36.06% above the market average36.06% above the market average36.06% above the market average36.06% above the market average
43.33% above the sector average43.33% above the sector average43.33% above the sector average43.33% above the sector average43.33% above the sector average
Momentum 20
25.32% above the market average25.32% above the market average25.32% above the market average25.32% above the market average25.32% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
65.5% below the market average65.5% below the market average65.5% below the market average65.5% below the market average65.5% below the market average
22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
53.05% below the market average53.05% below the market average53.05% below the market average53.05% below the market average53.05% below the market average
36.67% above the sector average36.67% above the sector average36.67% above the sector average36.67% above the sector average36.67% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
89.76% below the market average89.76% below the market average89.76% below the market average89.76% below the market average89.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Cash
78.58% below the market average78.58% below the market average78.58% below the market average78.58% below the market average78.58% below the market average
93.33% below the sector average93.33% below the sector average93.33% below the sector average93.33% below the sector average93.33% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
46.21% below the market average46.21% below the market average46.21% below the market average46.21% below the market average46.21% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
36.65% above the market average36.65% above the market average36.65% above the market average36.65% above the market average36.65% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 10.75p
Change Today -0.25p
% Change -2.27 %
52 Week High 33.25
52 Week Low 8.90
Volume 759,804
Shares Issued 102.32m
Market Cap £11.00m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.87% below the market average42.87% below the market average42.87% below the market average42.87% below the market average42.87% below the market average
45.76% below the sector average45.76% below the sector average45.76% below the sector average45.76% below the sector average45.76% below the sector average
Price Trend
79.99% below the market average79.99% below the market average79.99% below the market average79.99% below the market average79.99% below the market average
46.03% below the sector average46.03% below the sector average46.03% below the sector average46.03% below the sector average46.03% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Valirx Dividends

No dividends found

Trades for 31-Mar-2023

Time Volume / Share Price
16:28 1,990 @ 10.56p
15:57 436 @ 10.56p
15:56 6 @ 10.56p
15:38 129 @ 10.56p
15:30 15,000 @ 10.55p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page